Clinical studies in the development of n
โ
Ferry A.L.M Eskens; Jaap Verweij
๐
Article
๐
2000
๐
Elsevier Science
๐
English
โ 72 KB
Various new specifically targeted anticancer agents such as matrixmetalloproteinase inhibitors, angiogenesis inhibitors, farnesyl transferase inhibitors, and tyrosine kinase inhibitors have been developed in recent years. These agents exert antitumor activity through specific target inhibition, and